Skip to main content

Home / Combinations / TB-500 + PEG-MGF

CombinationRecoveryMuscle GrowthAnecdotal evidence

TB-500 + PEG-MGF

Muscle Repair & Regeneration

A complementary pairing of TB-500's systemic anti-inflammatory and actin-binding tissue-repair properties with PEG-MGF's localized satellite cell activation. Commonly researched for accelerating recovery from muscle injury and supporting lean tissue regeneration.

Stack components

TB-500Compound 01
PEG-MGFCompound 02
2
Compounds
2
Sources on file
7
Providers carry all
Mechanism

What each compound is researched for on its own. Nothing here describes an interaction between them.

Compound 01

TB-500

Actin-sequestering peptide that promotes systemic anti-inflammation, cell migration, and vascular remodeling to create a favorable repair environment throughout injured tissue.

Compound 02

PEG-MGF

Pegylated mechano growth factor that activates quiescent satellite cells at the site of muscle damage, driving local proliferation and fusion into new muscle fibers.

2 compounds · 2 research areas
Stated as recorded. This page describes each compound separately and makes no claim that they act together.
Safety notes

TB-500 has a systemic anti-inflammatory profile while PEG-MGF acts locally at the site of muscle stress. No formal human combination study exists; individual component safety profiles are generally reported as favorable in research settings.

Author-written. Not derived from any compound field, and not covered by the profile-integrity audit that gates the peptide pages.

Research references2 sources
Moderate
Thymosin β4: a multi-functional regenerative peptide. Basic properties and clinical applications
Expert Opin Biol Ther 2012
PeptideBase notePer-component source only — no combination study exists
Moderate
MGF splice variant of IGF-I: a local repair factor or systemic mediator
Ann N Y Acad Sci 2004
PeptideBase notePer-component source only — no combination study exists
no identifier on file
Related combinations3 share an area
Educational use only
PeptideBase documents what compounds are researched together and what evidence exists for each one separately. It does not provide medical advice, diagnosis, treatment, prescribing guidance or dosing instructions. Last reviewed 23 Apr 2026.

Free newsletter

The Peptide Research Digest

Weekly analysis on providers, sourcing and compounds — from the team behind PeptideBase.

No spam. Unsubscribe anytime. Privacy policy.